EWM
PTCT icon

Empirical Wealth Management’s PTC Therapeutics PTCT Stock Holding History

Empirical Wealth Management’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.3M Buy
15,916
+2,065
+15% +$149K 0.02% 349
2026
Q1 		$944K Buy
13,851
+1,217
+10% +$86.2K 0.02% 371
2025
Q4 		$960K Sell
12,634
-8,141
-39% -$592K 0.02% 343
2025
Q3 		$1.27M Buy
+20,775
New +$1.08M 0.03% 299

Other funds holding PTCT

Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
PFC
Phocas Financial Corp Alameda, California $721M AUM 63.77% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Empirical Wealth Management's PTCT Position: Q2 2026 in Review

Empirical Wealth Management increased its PTC Therapeutics (PTCT) stake by 15% in Q2 2026, buying an estimated $149K and bringing the position to 15,916 shares worth $1.3M. The position accounts for 0.02% of the portfolio, ranked #349.

Empirical Wealth Management first reported a position in PTCT in Q3 2025 and has held it in 4 quarters since. 115 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • Empirical Wealth Management held 15,916 shares of PTC Therapeutics worth $1.3M as of Q2 2026.
  • Empirical Wealth Management bought 2,065 PTC Therapeutics shares in Q2 2026, an estimated $149K.
  • PTC Therapeutics made up 0.02% of Empirical Wealth Management's portfolio in Q2 2026, its #349 holding.
  • Empirical Wealth Management first reported a position in PTC Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • 115 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Empirical Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.